Keyphrases
Desensitization
100%
Kidney Transplant Recipients
100%
Intravenous Immunoglobulin (IVIg)
100%
Calculated Panel Reactive Antibody
100%
HLA Antibodies
100%
Intravenous Rituximab
100%
Highly Sensitized
40%
Mean Fluorescence Intensity
40%
Desensitization Protocol
40%
Rebound Effect
40%
Immunomodulation
20%
Major Risk Factors
20%
Acute Rejection
20%
Transplant Recipients
20%
Human Leukocyte Antigen
20%
Kidney Transplant
20%
Antibody Concentration
20%
Rituximab
20%
Donor-specific Antibodies
20%
Human Leukocyte Antigen Antibodies
20%
Chronic Antibody-mediated Rejection
20%
Antibody Profile
20%
Antibody Reduction
20%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
HLA Antibody
100%
Rituximab
100%
Immunology
100%
Panel Reactive Antibody
71%
Rebound
42%
Human Leukocyte Antigen
28%
Antibody Blood Level
14%
Immune Complex
14%
Immunomodulation
14%
Chronic Graft Rejection
14%
Antibody Mediated Rejection
14%
Antibodies
14%